Tamara M. Morytko
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tamara M. Morytko
Tamara M. Morytko was last confirmed as Board Member at Flowserve Corp (FLS) in a filing dated March 31, 2022. The proxy statement of Flowserve Corp reports total compensation of $1,757,050 for Tamara M. Morytko in fiscal 2022, including a base salary of $554,548. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-01–2022-03-31
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Flowserve Corp (FLS) | Former President, Flowserve Pumps Division Represents the grant date fair value of long-term equity incentive awards under the Company’s long-term incentive program computed in accordance with FASB ASC 718 “Compensation—Stock Compensation”, excluding the impact of forfeitures. Stock awards include the annual incentive awards granted in the form of restricted stock units that generally vest ratably over a three-year period and contingent performance share units. The performance criteria for the performance share units are described in further detail under the caption “2022 Executive Compensation Decisions—Long Term Incentives” above. The reported value of the performance share units is computed based on the grant date estimate of compensation cost to be recognized over the three-year period, which was 100%, or “target”. Payout for the contingent performance awards can range from 0 shares to a maximum of 230% of target. Assumptions used in the valuations are discussed in Note 7 to the Company’s audited consolidated financial statements for the year ended December 31, 2022 in the Annual Report. The amounts in this column represent an annual cash incentive award under the Company’s Annual Incentive Plan for the applicable year. This column excludes the employer-paid portion of certain health and welfare benefits received by Named Executive Officers that are available generally to all salaried U.S. employees, which includes medical, dental and vision insurance, and short-term and long-term disability insurance. The following table shows the components of this column for the Named Executive Officers for 2022, calculated at the aggregate incremental cost to the Company: | $554,548 | $1,757,050 |
| 2021 | Flowserve Corp (FLS) | President, Flowserve Pumps Division Represents the grant date fair value of long-term equity incentive awards under the Company’s long-term incentive program computed in accordance with FASB ASC 718 “Compensation—Stock Compensation”, excluding the impact of forfeitures. Stock awards include the annual incentive awards granted in the form of restricted stock units that generally vest ratably over a three-year period and contingent performance share units. Stock awards also include the 2021 enhanced LTI awards discussed above under the caption “2021 Executive Compensation Oucomes—Long Term Incentives—One-Time, Enhanced LTI Awards”, which vest one-third after 2 years and two-thirds after 3 years. The performance criteria for the performance share units are described in further detail under the caption “2021 Executive Compensation Outcomes—Long-Term Incentives” above. The reported value of the performance share units is computed based on the grant date estimate of compensation cost to be recognized over the three-year period, which was 100%, or “target”. Payout for the contingent performance awards can range from 0 shares to a maximum of 230% of target. Assumptions used in the valuations are discussed in Note 8 to the Company’s audited consolidated financial statements for the year ended December 31, 2021 in the Annual Report. The amounts in this column represent an annual cash incentive bonus under the Company’s Annual Incentive Plan for the applicable year. There were no above-market or preferential earnings with respect to any deferred compensation balances. This column excludes the employer-paid portion of certain health and welfare benefits received by Named Executive Officers that are available generally to all salaried U.S. employees, which includes medical, dental, vision and prescription insurance, and short-term and long-term disability insurance. The following table shows the components of this column for the Named Executive Officers for 2021, calculated at the aggregate incremental cost to the Company: | $525,577 | $1,976,093 |
Recent activity
No call appearances or filed executive changes recorded yet.